GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RARE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Ultragenyx Pharmaceutical Inc.
(Updated on Apr 17, 2024)

Sell candidate since Apr 12, 2024 Loss -6.15% PDF

The Ultragenyx Pharmaceutical Inc. stock price gained 4.25% on the last trading day (Wednesday, 17th Apr 2024), rising from $42.31 to $44.11. During the last trading day the stock fluctuated 5.63% from a day low at $42.25 to a day high of $44.63. The price has fallen in 5 of the last 10 days and is down by -6.31% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 thousand more shares were traded than the day before. In total, 890 thousand shares were bought and sold for approximately $39.25 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $42.35 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.33% during the next 3 months and, with a 90% probability hold a price between $44.61 and $58.07 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RARE Signals & Forecast

There are mixed signals in the stock today. The Ultragenyx Pharmaceutical Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $47.02 and $48.26. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 4.25%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Ultragenyx Pharmaceutical Inc. stock

Ultragenyx Pharmaceutical Inc. finds support from accumulated volume at $43.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.38 between high and low, or 5.63%. For the last week, the stock has had daily average volatility of 5.76%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RARE) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Ultragenyx Pharmaceutical Inc. to open at $43.66, and during the day (based on 14 day Average True Range), to move between $41.87 and $46.35, which gives a possible trading interval of +/-$2.24 (+/-5.07%) up or down from last closing price. If Ultragenyx Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 10.14% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $44.60 (1.11%) than the support at $43.16 (2.15%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ultragenyx Pharmaceutical Inc. stock A Buy?

Ultragenyx Pharmaceutical Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.070 Sell Candidate Unchanged

Predicted Opening Price for Ultragenyx Pharmaceutical Inc. of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$43.66 ( 1.01%) $44.11

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RARE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 46.04 4.38 %
R2 45.13 2.32 %
R1 44.57 1.05 %
Current price: 44.11
Support S1 42.75 -3.07 %
S2 42.19 -4.35 %
S3 41.28 -6.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 47.37 7.39 %
R2 47.00 6.55 %
R1 44.60 1.11 %
Current price 44.11
Support S1 43.16 -2.15%
S2 42.87 -2.81%
S3 42.31 -4.08%

FAQ

What is the symbol for Ultragenyx Pharmaceutical Inc. Stock and on which exchange is it traded?
The symbol for Ultragenyx Pharmaceutical Inc. is RARE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ultragenyx Pharmaceutical Inc. Stock?
Ultragenyx Pharmaceutical Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Ultragenyx Pharmaceutical Inc. Stock?
Ultragenyx Pharmaceutical Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ultragenyx Pharmaceutical Inc. Stock.

What's the current price of Ultragenyx Pharmaceutical Inc. Stock?
As of the end of day on the 2024-04-17, the price of an Ultragenyx Pharmaceutical Inc. (RARE) share was $44.11.

What is the 52-week high and low for Ultragenyx Pharmaceutical Inc. Stock?
The 52-week high for Ultragenyx Pharmaceutical Inc. Stock is $54.98 and the 52-week low is $31.52.

What is the market capitalization of Ultragenyx Pharmaceutical Inc. Stock?
As of the 2024-04-17, the market capitalization of Ultragenyx Pharmaceutical Inc. is 3.632B.

When is the next earnings date for Ultragenyx Pharmaceutical Inc.?
The upcoming earnings date for Ultragenyx Pharmaceutical Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT